Colrain Capital’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.17M | Buy |
104,950
+50,495
| +93% | +$4.84M | 3.54% | 15 |
|
|
2025
Q4 | $5.27M | Buy |
54,455
+3,860
| +8% | +$375K | 2.9% | 15 |
|
|
2025
Q3 | $4.85M | Buy |
50,595
+15,355
| +44% | +$1.41M | 2.77% | 19 |
|
|
2025
Q2 | $3.1M | Sell |
35,240
-3,560
| -9% | -$302K | 2.39% | 19 |
|
|
2025
Q1 | $3.51M | Buy |
38,800
+740
| +2% | +$66.2K | 3% | 17 |
|
|
2024
Q4 | $3.07M | Buy |
+38,060
| New | +$3.29M | 3.01% | 12 |
|
|
2022
Q3 | $1.55M | Buy |
19,100
+100
| +0.5% | +$8.99K | 2.59% | 20 |
|
|
2022
Q2 | $1.72M | Hold |
19,000
| – | – | 2.69% | 20 |
|
|
2022
Q1 | $2.12M | Buy |
19,000
+2,500
| +15% | +$264K | 2.96% | 19 |
|
|
2021
Q4 | $1.72M | Buy |
16,500
+5,000
| +43% | +$579K | 2.07% | 19 |
|
|
2021
Q3 | $1.45M | Hold |
11,500
| – | – | 2.71% | 18 |
|
|
2021
Q2 | $1.44M | Sell |
11,500
-15,700
| -58% | -$1.97M | 2.58% | 18 |
|
|
2021
Q1 | $3.21M | Buy |
27,200
+13,600
| +100% | +$1.59M | 3.3% | 15 |
|
|
2020
Q4 | $1.59M | Hold |
13,600
| – | – | 3.24% | 15 |
|
|
2020
Q3 | $1.41M | Sell |
13,600
-2,127
| -14% | -$214K | 3.41% | 16 |
|
|
2020
Q2 | $1.44M | Sell |
15,727
-4,400
| -22% | -$422K | 3.16% | 15 |
|
|
2020
Q1 | $1.81M | Sell |
20,127
-4,000
| -17% | -$426K | 3.41% | 15 |
|
|
2019
Q4 | $2.74M | Sell |
24,127
-1,800
| -7% | -$198K | 2.87% | 15 |
|
|
2019
Q3 | $2.82M | Hold |
25,927
| – | – | 3.1% | 14 |
|
|
2019
Q2 | $2.52M | Hold |
25,927
| – | – | 2.84% | 15 |
|
|
2019
Q1 | $2.36M | Sell |
25,927
-374
| -1% | -$33.5K | 2.77% | 19 |
|
|
2018
Q4 | $2.39M | Hold |
26,301
| – | – | 3.11% | 18 |
|
|
2018
Q3 | $2.59M | Hold |
26,301
| – | – | 2.76% | 20 |
|
|
2018
Q2 | $2.25M | Sell |
26,301
-4,399
| -14% | -$367K | 2.65% | 19 |
|
|
2018
Q1 | $2.46M | Sell |
30,700
-6,770
| -18% | -$558K | 2.61% | 19 |
|
|
2017
Q4 | $3.03M | Sell |
37,470
-30,088
| -45% | -$2.41M | 2.5% | 21 |
|
|
2017
Q3 | $5.25M | Sell |
67,558
-8,700
| -11% | -$722K | 2.41% | 21 |
|
|
2017
Q2 | $6.77M | Sell |
76,258
-26,915
| -26% | -$2.27M | 2.75% | 15 |
|
|
2017
Q1 | $8.31M | Sell |
103,173
-51,602
| -33% | -$4.03M | 2.5% | 15 |
|
|
2016
Q4 | $11M | Sell |
154,775
-9,725
| -6% | -$764K | 2.31% | 18 |
|
|
2016
Q3 | $14.2M | Sell |
164,500
-28,850
| -15% | -$2.51M | 3.21% | 9 |
|
|
2016
Q2 | $16.8M | Sell |
193,350
-35,650
| -16% | -$2.88M | 3.35% | 7 |
|
|
2016
Q1 | $17.2M | Sell |
229,000
-177,750
| -44% | -$13.4M | 2.99% | 13 |
|
|
2015
Q4 | $31.3M | Sell |
406,750
-31,250
| -7% | -$2.35M | 3.17% | 13 |
|
|
2015
Q3 | $29.3M | Buy |
438,000
+113,500
| +35% | +$8.36M | 3.06% | 13 |
|
|
2015
Q2 | $24M | Buy |
324,500
+193,700
| +148% | +$14.8M | 2.12% | 23 |
|
|
2015
Q1 | $10.2M | Buy |
+130,800
| New | +$9.91M | 0.85% | 33 |
|
Other funds holding MDT
VCM
VPM
Colrain Capital's MDT Position: Q1 2026 in Review
Colrain Capital increased its Medtronic (MDT) stake by 93% in Q1 2026, buying an estimated $4.84M and bringing the position to 104,950 shares worth $9.17M. The position accounts for 3.54% of the portfolio, ranked #15.
Colrain Capital first reported a position in MDT in Q1 2015 and has held it in 37 quarters since. The position peaked at $31.3M in Q4 2015. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Colrain Capital held 104,950 shares of Medtronic worth $9.17M as of Q1 2026.
- Colrain Capital bought 50,495 Medtronic shares in Q1 2026, an estimated $4.84M.
- Medtronic made up 3.54% of Colrain Capital's portfolio in Q1 2026, its #15 holding.
- Colrain Capital first reported a position in Medtronic in Q1 2015 and has held it in 37 quarters since.
- Colrain Capital's Medtronic position peaked at $31.3M in Q4 2015.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Colrain Capital's 13F filing for Q1 2026, filed 12 May 2026.